This content is in French.
An antiviral reassigned to fight RSV?
15 février 2024
Respiratory syncytial virus (RSV) is responsible for acute lower respiratory tract infections in infants, the elderly and the immunocompromised. Currently, there are no antiviral drugs with a direct action on RSV. In…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Svenja M Sake et al. Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nat Commun. 2024 Feb 8;15(1):1173.
View the source
